Evidence map›Paper›PMID 33184119›Full record

ArticleThe European respiratory journal2021

Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe.

Vladyslav Nikolayevskyy, Yen Holicka, Dick van Soolingen, Marieke J van der Werf, Csaba Ködmön, Elena Surkova, Doris Hillemann, Ramona Groenheit, ERLTB-Net-2 study participants, Daniela Cirillo

Abstract readLetter
In one paragraph

Article in The European respiratory journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Increase in tuberculosis among children and young adolescents, European Union/European Economic Area, 2015 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Ending tuberculosis in Europe - resetting the course in the post-COVID-19 era.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
  9. Monitoring the progress achieved towards ending tuberculosis in the European Union/European Economic Area, 2018 to 2021.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Multiple CD59 Polymorphisms in Chinese Patients withJournal of immunology research · 2023
    Article
  15. The European Union One Health 2021 Zoonoses Report.EFSA journal. European Food Safety Authority · 2022
    Article
  16. Article
  17. Tuberculosis in an Aging World.Pathogens (Basel, Switzerland) · 2022
    Review
  18. Article
  19. The COVID-19 and TB syndemic: the way forward.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2022
    Review
  20. Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Vladyslav NikolayevskyyPublic Health England, London, UK.ORCID 0000-0002-9502-0332
Yen HolickaPublic Health England, London, UK.
Dick van SoolingenNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Marieke J van der WerfEuropean Centre for Disease Prevention and Control, Solna, Sweden.ORCID 0000-0001-8021-1358
Csaba KödmönEuropean Centre for Disease Prevention and Control, Solna, Sweden.
Elena SurkovaRoyal Brompton Hospital, London, UK.
Doris HillemannNational Reference Centre for Mycobacteria, Borstel, Germany.
Ramona GroenheitPublic Health Agency of Sweden, Stockholm, Sweden.
ERLTB-Net-2 study participants
Daniela CirilloSan Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0001-6415-1535

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Diagnostic ServicesEuropeHumansTuberculosis

Identifiers

PMID33184119
PMCPMC7670866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.